Fintel reports that on June 28, 2024, Barclays initiated coverage of Charles River Laboratories International (NYSE:CRL) with a Equal-Weight recommendation.
https://www.nasdaq.com/articles/barclays-initiates-coverage-charles-river-laboratories-international-crl-equal-weight